Latest Press Releases

January 8, 2026 News

Novotech appoints Anand Tharmaratnam as new CEO

Singapore, 8 January 2026 – Novotech, a globally recognized full-service biotech...

Read more Notification Icon
December 16, 2025 News

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution

Sydney, Australia, December 2025, Novotech, a leading global full-service clinic...

Read more Notification Icon
October 31, 2025 News

Novotech Maps Global Growth in Radiopharmaceutical Trials

Sydney, Australia, October 2025 — Novotech, a leading global clinical research o...

Read more Notification Icon
August 29, 2025 News

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue…

SYDNEY, Australia – August 28, 2025, Novotech, a globally recognized full-servic...

Read more Notification Icon
View all Press Releases

Latest Disease Reports

April 19, 2025 Report

Obesity: Global Clinical Trial Landscape (2025)

Explore the evolving treatment landscape for obesity through Novotech CRO’s latest disease report....

Download
April 10, 2025 Report

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Idiopathic Pulmonary Fibrosis through Novotech CRO's in-depth disease analysis....

Download
February 26, 2025 Report

Hepatitis B: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Hepatitis B through Novotech CRO's in-depth disease analysis....

Download
January 7, 2025 Report

Triple-Negative Breast Cancer: Global Clinical Trial Landscape (2024)

Discover the latest advancements in triple-negative breast cancer through Novotech CRO's in-depth disease analysis....

Download
View all Disease Reports

Latest White Papers

December 4, 2025 Whitepaper

The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology

Early-phase oncology trials mark the most critical and fast-evolving stage of cancer research...

Download
October 15, 2025 Whitepaper

Therapeutic Radiopharmaceuticals: Download 2025 Global Report

Unlocking the Future of Precision Oncology with Therapeutic Radiopharmaceuticals....

Download
July 2, 2025 Whitepaper

2025 Global Report for In-Vivo CAR Cell Therapy

Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases....

Download
June 12, 2025 Whitepaper

Live Biotherapeutic Products Whitepaper 2025

Live biotherapeutic products (LBPs) are gaining momentum in the drug development space, emphasisin...

Download
View all White Papers

Latest webinars

February 19, 2026 Webinar

Translating Early-Phase Radiopharma Innovation into Clinical Success: Perspectives from…

How do you turn early-phase radiopharmaceutical innovation into clinical success? This expert-led webinar will explore how early…

Watch
November 18, 2025 Webinar

Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions

This webinar will explore the evolving landscape of B cell–targeting therapies in autoimmune diseases. Expert panelists will…

Watch
October 30, 2025 Webinar

Obesity, from the bench to the bedside: Science, Solutions, and Stories

This webinar will explore the biological, clinical, and societal impact of obesity while highlighting opportunities to advance…

Watch
June 26, 2025 Webinar

Mitigating Risk with Ex-US Clinical Trials

This expert-led webinar explores how ex-US clinical trials can help biotech and mid-size pharma companies accelerate development…

Watch
View all webinars

Latest Podcasts

March 6, 2026 Podcast

Global Strategies for Radiopharmaceutical Clinical Trials

Episode description:  Radiopharmaceutical trials are growing quickly, but execution is rarely straightforward. In this episode, Novotech’s Senior Project Manage Stacey...
March 4, 2026 Podcast

Key Early-Phase Decisions in B Cell–Targeted Autoimmune Therapies

Episode description:Watch the webinar: Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions.  B cell–targeted therapies are becoming an...
February 9, 2026 Podcast

Obesity, From Bench to Bedside: Science, Solutions, and Stories

Episode description:Obesity drug development is moving faster than any other metabolic area and success now depends on more than efficacy...
December 4, 2025 Podcast

Charting the Next Chapter in Obesity Therapeutics

Episode description:More than 1.13 billion adults are living with obesity worldwide. In this episode, experts explain what’s driving the rise,...
View all Podcasts

Latest events

April 15-16, 2026 Events

DIA Korea Annual Meeting 2026

South Korea

Read More
March 18-20, 2026 Events

CMAC 2026

Suzhou, China

Read More
April 14-15, 2026 Events

BioTrinity 2026

Convene, 133 Houndsditch, London, EC3A 7BX

Read More
March 27, 2026 Events

NECTA 2026

Sydney, Australia

Read More
View all events

Latest articles

March 20, 2026 Article

Breaking Through the Checkpoint Blockade in Immuno-Oncology

Immuno-oncology is moving beyond first-generation checkpoint inhibitors, with new approaches such as bispecific antibodies, T-cell engagers, and bi...

Read more
January 28, 2026 Article

South Korea and Australia Offer Solutions for Radiopharmaceutical Trial Bottlenecks

Published in Clinical Trials Arena, this article examines how Australia and South Korea are addressing key bottlenecks in radiopharmaceuti...

Read more
January 9, 2026 Article

The Future of Obesity Drugs Starts in Preclinical Discovery

The future of obesity drugs is being shaped long before clinical trials, in preclinical discovery....

Read more
December 18, 2025 Article

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

In-vivo CAR-T therapy delivers genetic instructions to immune cells inside the patient, aiming to reduce ex-vivo manufacturing constraints, shorten time...

Read more
View all articles

Latest blogs

February 26, 2026 Blog

Next-Generation CAR Therapies Beyond Oncology: In Vivo Delivery, Smarter Targeting, and New…

...

Read more
January 29, 2026 Blog

Australian Centre for Disease Control: What It Means for the Future of Clinical Research

Australia has taken a significant step toward strengthening national public health infrastructure with legislation establishing a permanent, independent Australian Centre...

Read more
December 16, 2025 Blog

ASH 2025: Signals for 2026 Hematology Planning

By: Sarah Anderson, Director Therapeutic Strategy & Pedro Rodriguez-Noriega, Associate Therapeutic Strategy Manag...

Read more
December 4, 2025 Blog

Europe At A Crossroads: Biotech Investment, Regulation And Partnership In Real Life

Earlier this month, our team joined a select group of investors, biotech leaders and policy experts to talk about the...

Read more
View all blogs

Latest case studies

March 20, 2026 Case Study

Accelerating First-in-Human Start-Up for a Complex GMO Oncology Clinical Trial

Overviewology clinical trial was designed to evaluate safety, tolerability, dose escalation, pharmacokinetics (PK), pharmacodyna...

Read More
January 22, 2026 Case Study

Phase III IPF Clinical Trial Delivered Across Asia-Pacific

A multinational Phase III, randomized, double-blind, placebo-controlled IPF study conducted across Australia, South Korea, Hong Kong, and...

Read More
September 5, 2025 Case Study

Accelerating Obesity Drug Development in Australia and New Zealand with Novotech

Addressing a Global Health PriorityObesity is one of the fastest-growing global health challenges, affecting more than 1 billion...

Read More
November 15, 2024 Case Study

Indian Biotech Phase IIB

BackgroundA biotech company based in India embarked on a Phase IIb clinical trial t...

Read More
View all case studies

Latest Frequently Asked Questions

December 4, 2025 FAQ

How Is Early-phase Oncology Shaping The Next Generation Of Cancer Therapies?

Gain insight into the emerging platforms, regulatory shifts, and clinical advances that are redefining early-phase oncology....

Read More
October 15, 2025 FAQ

How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?

Uncover the science, clinical applications, and global momentum behind this rapidly growing treatment modality....

Read More
July 2, 2025 FAQ

What makes in-vivo CAR therapies the next frontier in cell therapy?

Explore key questions and answers to learn how this innovative approach is transforming treatment possibilities.&nb...

Read More
June 12, 2025 FAQ

FAQs on Live Biotherapeutic Products

Live biotherapeutic products contain a single species or consortium of live microorganisms such as bacteria or yeast isolated from human...

Read More
View all Frequently Asked Questions